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Summary
Objective: To evaluate the psychometric properties of the French KOOS physical function (KOOS-PS) and HOOS physical function (HOOS-
PS), speciﬁcally its feasibility, reliability, construct validity, and responsiveness.
Methods: Consecutive outpatients consulting for primary knee or hip osteoarthritis (OA) in a rheumatology department were included. During
the initial assessment, patients were asked to complete the Knee injury and Osteoarthritis Outcome Score (KOOS) or Hip disability and
Osteoarthritis Outcome Score (HOOS) questionnaire and the OsteoArthritis Knee and Hip Quality Of Life questionnaire (OAKHQOL). The pa-
tients were given a second KOOS or HOOS questionnaire to complete and return by mail 2 weeks later.
Feasibility was assessed by calculating the percentage of missing items and the ﬂoor and ceiling effects. Testeretest reliability was evaluated
using the intra-class correlation coefﬁcient (ICC). Convergent and divergent construct validity was determined by comparing the results of the
KOOS-PS or HOOS-PS and OAKHQOL questionnaires using Spearman’s rank test. Responsiveness was evaluated using data obtained in
other hip or knee OA patients prior to and 1 month after intra-articular hyaluronic acid injection, using standardized response mean (SRM) and
effect-size (ES).
Results: Eighty-seven patients with knee OA and 50 hip OA patients were included. The KOOS-PS and HOOS-PS scores were obtained for
all patients as there were no missing items. Neither a ﬂoor nor a ceiling effect was observed. The ICC of KOOS-PS and HOOS-PS was 0.861
(0.763e0.921) and 0.859 (0.725e0.929), respectively. A strong or moderate correlation was observed, as expected, between KOOS-PS,
HOOS-PS, and the OAKHQOL physical activities, pain, and mental health domains. A weak correlation was observed, as expected, between
KOOS-PS, HOOS-PS, and the other OAKHQOL domains, except for a moderate correlation between the KOOS-PS and social functioning.
The responsiveness was demonstrated with SRM and ES of 0.80 and 0.51 (KOOS-PS), 1.10 and 0.62 (HOOS-PS), respectively.
Conclusion: The French versions of KOOS-PS and HOOS-PS are reliable, valid, and responsive questionnaires for capturing functional dis-
ability in people with knee and hip OA.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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1604hip, as well as the hand joints. The pain and disability asso-
ciated with knee and hip OA have a signiﬁcant impact on the
patients’ health-related quality of life1,2. As the frequency of
knee and hip OA increases as a result of life-style changes
associated with higher body mass index (BMI) and less
physical activity and the aging of the population, this disorder
increasingly will become a major health problem. Thus, it is
important to evaluate interventions that might decrease
patients’ disability and/or prevent or delay the progression
of the disease.
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function in knee and hip OA patients1,3e5. In particular,
the Western Ontario and McMaster Universities Index
(WOMAC) is a validated and widely used disease-speciﬁc
instrument, which assesses OA-induced pain, stiffness,
and functional limitations6. Since there were concerns that
the WOMAC physical function subscale did not include
items of sufﬁcient difﬁculty, the Knee injury and Osteoarthri-
tis Outcome Score (KOOS) and Hip disability and Osteoar-
thritis Outcome Score (HOOS) were developed as an
extension of the WOMAC7e12. Recently, a working group
created under the auspices of OARSI (Osteoarthritis Re-
search Society International) and OMERACT (Outcome
Measures in Rheumatology Clinical Trials) considered
what would be an optimal tool to evaluate physical function
states that represent the progression of physical disability
from early to late disease for individuals with OA of the
hip and knee)13,14. Of primary consideration were items
that represented the spectrum of disability in a short mea-
sure with appropriate measurement properties. Using the
Rasch analysis and data from samples representing a spec-
trum of OA severity, the group developed short measures of
physical function in knee and hip OA that represent the pro-
gression of physical disability, the KOOS physical function
(KOOS-PS) and HOOS physical function (HOOS-PS)13,14.
These short measures are derived from the KOOS and
HOOS and are reduced to seven (KOOS-PS) and ﬁve
(HOOS-PS) items, achieving feasible, short scales with in-
terval measurement properties that can be used as a func-
tion component of a knee and hip OA severity scoring
system, covering a range of difﬁculty.
Due to the increase in large multicenter international stud-
ies and the requirement for globally meaningful epidemio-
logic and/or therapeutic study results, there is a need for
cross-cultural adaptation and validation of health status
measures. Moreover to assess a potential outcome mea-
sure, it is necessary to assess its psychometric properties,
as deﬁned by the OMERACT ﬁlter. The OMERACT ﬁlter15
checks that a potential outcome measure is truthful, i.e., re-
ﬂects what it is supposed to reﬂect, and is discriminant, which
includes reproducibility, and sensitivity to change, over time,
and between different severity stages. The last element in
the OMERACT ﬁlter refers to feasibility, which relates to
time, cost, availability and is not assessed through statistics.
The aim of the present study was to evaluate the psycho-
metric properties of the French KOOS-PS and HOOS-PS,
as expressed by its feasibility, reliability, construct validity,
and responsiveness.MethodsSTUDY DESIGN, PROSPECTIVE STUDYPatients
Consecutive outpatients consulting for knee or hip OA in the rheumatol-
ogy department of the Dijon University Hospital (France) were included.
The inclusion criteria were patient age of at least 40 years, and primary
knee or hip OA according to the American College of Rheumatology criteria16.
Patients had to be able to understand and complete the self-report question-
naires. In patients evaluated for responsiveness, an additional inclusion cri-
terion was indication for intra-articular hyaluronate injection, according to the
rheumatologist’s usual criterion.
The exclusion criteria were the presence of other signiﬁcant rheumatic dis-
ease, such as low back pain and other lower limb joint OA, severe inﬂamma-
tory arthritis as conﬁrmed by physical examination, and intra-articular use of
corticosteroids within the previous 3 months. In patients evaluated for reliabil-
ity, an additional exclusion criterion was expected changes in knee or hip OA
treatment during the following 2 weeks. In patients evaluated for responsive-
ness, an additional exclusion criterion was expected changes in knee or hip
OA treatment during the following month, except for hyaluronate injection.Questionnaires
During the initial assessment, patients were asked to complete the French
versions of KOOS or HOOS questionnaires. The translation and cross-cultural
adaptation process of KOOSandHOOS into French have been conducted ac-
cording to recommendations and have been described elsewhere17,18.
Brieﬂy, three persons (two rheumatologists and one teacher of English) native
in the target language translated independently the English versions into
French. A ﬁnal single version was obtained after a consensus meeting. Back-
ward translation was then performed by a bilingual native English speaker,
blinded to the English original version. In the next step, a multidisciplinary con-
sensus committee had a meeting in order to ensure that the translation was
fully comprehensive and to verify cross-cultural equivalence of the source
and ﬁnal versions. In the last step, the ﬁnal version was pre-tested among
15 French patients suffering from knee and 15 from hip OA. The KOOS-PS
and HOOS-PS include seven (rising from bed, putting on socks/stockings, ris-
ing from sitting, bending to the ﬂoor, twisting/pivoting on your injured knee,
kneeling, squatting) and ﬁve (descending stairs, getting in/out of bath, sitting,
running, twisting/pivoting on your loaded leg) items, respectively, which were
extracted in order to calculate the KOOS-PS and HOOS-PS scores. The
scores were obtained as described: scored on 0e28 and 0e20 scales, re-
spectively, then normalized on a 0e100 scale, 0 being the best13,14. Patients
evaluated for validity also completed the OsteoArthritis Knee and Hip Quality
Of Life questionnaire (OAKHQOL) during the initial assessment. The OAKH-
QOL was recently validated as a speciﬁc hip and knee OA quality of life instru-
ment19. The OAKHQOL contains 43 items spread over ﬁve domains (pain,
physical activities, mental health, social support and social functioning) and
three independent items (sexual activity, relationships, and professional
life). Scores range from 0 (worst) to 100 (best).
Patients evaluated for reliability were given a second KOOS or HOOS
questionnaire that was completed and returned by mail 2 weeks later, using
a pre-stamped envelope. This length of time was chosen since it was as-
sumed that it was sufﬁciently important to consider that patients would not re-
member what they responded to the ﬁrst questionnaire, and sufﬁciently brief to
consider that no signiﬁcant change in knee or hip OA disability would occur.
Patients evaluated for responsiveness were treated with intra-articular in-
jection of hyaluronic acid. Patients with hip OA were given one ultrasound-
guided intra-articular hyaluronic acid injection. The indication for injection
was based on the usual criteria of the treating rheumatologist, but the proce-
dure was performed by the same physician (PO). The hyaluronic acid varied
in nature and molecular weight since patients presented with a speciﬁc pre-
scription from their treating rheumatologist. Patients with knee OA were
given three injections at 1-week intervals. The procedure was not ultra-
sound-guided, and was performed by the treating rheumatologist. Again,
the hyaluronic acid varied in nature and molecular weight. The patients
were given a second KOOS or HOOS questionnaire which they were asked
to complete 1 month after the last injection, and mail back, using a pre-
stamped envelope.
For the KOOS-PS and HOOS-PS, when at least one item was missing,
the score was not calculated. For OAKHQOL, when at least half of the items
of a dimension were missing, the score was not calculated. When fewer
items were omitted, missing values were replaced by the average of values
observed in the same domain for the individual.STATISTICAL ANALYSISFeasibility
Feasibility was assessed using the percentages of missing items and us-
ing the ﬂoor and ceiling effects. Floor and ceiling effects were considered
present if more than 15% of the respondents achieved the highest or lowest
possible scores.
Reliability
The testeretest reliability of the KOOS-PS and HOOS-PS was assessed
using the two questionnaires completed at a 2-week interval. Evaluation of
the reliability used the intra-class correlation coefﬁcient (ICC) (two way
model, single measure), with 95% CI (conﬁdence interval). An ICC of more
than 0.8 is usually considered to be indicative of excellent reproducibility.
In addition, the Bland and Altman representation, in which the difference be-
tween the ﬁrst and the second assessment is plotted against the mean of the
two assessments, was obtained. Such a representation allows describing the
percentage of the subjects and their distribution within the 95% limits of
agreements along the range of the score scale.
Construct validity
Convergent and divergent construct validity was determined by compar-
ing the results of the KOOS-PS or HOOS-PS and OAKHQOL question-
naires. The Spearman rank correlation was used to assess the association
between domains. Coefﬁcient correlations >0.5, 0.5e0.35, and <0.35
were considered as strong, moderate, and weak, respectively20. A priori hy-
potheses were generated for convergent (moderate to strong correlation
1606 P. Ornetti et al.: Psychometric properties of KOOS-PS and HOOS-PSexpected) and divergent (weak correlation expected) construct validity, ac-
cording to the theoretical measurement of similar or divergent constructs
and to data of the literature. It was hypothesized that the KOOS-PS and
HOOS-PS would correlate strongly or moderately with the OAKHQOL pain
and physical activities domains, as well as with the mental health domain,
since this particular domain has been shown to be strongly related to the
WOMAC function subscale19. On the other hand, it was hypothesized that
the KOOS-PS and the HOOS-PS would be weakly related with the other
OAKHQOL domains.
Responsiveness
The responsiveness was evaluated by comparing the pre- and 1-month
post-hyaluronic acid injection results. The standardized response mean
(SRM), i.e., the mean change between baseline and 1 month after injec-
tion divided by the standard deviation (SD) of the mean change; and
the effect-size (ES), i.e., the mean score change between baseline and
1 month after injection divided by the SD of the pre-injection values,
were calculated.
The Statistical Package for the Social Sciences (SPSS) version 14.0 was
used for data management and statistical analyses. Statistical signiﬁcance
was deﬁned as P< 0.05.
Results
A total of 49 patients with knee OA (mean age¼ 72 9
years, 71% women) were included in the reliability assess-
ment, of which 36 were also included in the construct val-
idity assessment. Among these 49 patients, 46 returned
their 2-week questionnaires. Responsiveness was evalu-
ated in 38 other patients, who all mailed back their 1-month
post-injections questionnaires.
A total of 30 patients with hip OA (mean age¼ 65 10
years, 74% women) were included in the reliability and con-
struct validity assessment. All returned their 2-week ques-
tionnaires. Responsiveness was evaluated in 20 other
patients, who all mailed back their 1-month post-injections
questionnaires.
As no individual item was missing, the KOOS-PS and
HOOS-PS scores were calculated in all patients for all as-
sessments. Except for three independent items not used
to calculate the different subscales (ability to work whereas
most patients were retired, and sexual activity), the OAKH-
QOL questionnaires were ﬁlled in correctly, allowing calcu-
lation of the different subscales in all patients.
Neither a ceiling nor ﬂoor effect was observed as no pa-
tient had a maximal or minimal KOOS-PS or HOOS-PS
score at either time of questionnaire completion.
The reproducibility of KOOS-PS and HOOS-PS was ex-
cellent (Table I). The Bland and Altman graphic representa-
tions are shown in Fig. 1. The difference between repeated
measurements was included in the limits of agreements in
most of cases, and was not related to the mean of the
two measurements.
The results of convergent and divergent validity are
shown in Table II. Eight out of 10 a priori hypotheses
were conﬁrmed. A strong or moderate correlation was ob-
served, as expected, between KOOS-PS, HOOS-PS, and
the OAKHQOL physical activities, pain, and mental healthTable I
Mean KOOS-PS and HOOS-PS scores and reliability of KOOS-PS
and HOOS-PS. Two assessments, separated by a 2-week interval,
were made
First
assessment:
mean (SD)
Second
assessment:
mean (SD)
ICC (95% CI)
KOOS-PS 48.3 (12.8) 49.1 (12.2) 0.861 (0.763e0.921)
HOOS-PS 51.1 (7.7) 52.1 (18) 0.859 (0.725e0.929)domains. A weak correlation was observed, as expected,
between KOOS-PS, HOOS-PS, and the other OAKHQOL
domains, except for a moderate correlation between the
KOOS-PS and social functioning.
The responsiveness of KOOS-PS and HOOS-PS demon-
strated large effects. Following the intra-articular injection,
the KOOS-PS and HOOS-PS were improved after in com-
parison to before intra-articular injection in a great majority
of patients (33 out of 38 and 17 out of 20, respectively).
The SRM and ES were 0.80 and 0.51 (KOOS-PS) and
1.1 and 0.62 (HOOS-PS), respectively (Table III).
Discussion
In the present work, the psychometric properties of the
KOOS-PS and HOOS-PS were evaluated and found to be
satisfactory. However, the ﬁndings will have to be conﬁrmed
by further studies evaluating other OA subpopulations be-
fore more extensive generalizability of the measures can
be demonstrated. The data used in the present study
were extracted from KOOS and HOOS questionnaires.
Thus, the results will need conﬁrmation with patients
completing speciﬁcally the KOOS-PS and HOOS-PS
questionnaires.
The results of the correlations support a convergent and
divergent validity of KOOS-PS and HOOS-PS. As ex-
pected, higher correlations occurred when comparing
KOOS-PS and HOOS-PS with the OAKHQOL subscale
measuring the same domain (physical activity). The rela-
tionship with the OAKHQOL pain domain is in accordance
with previous studies which demonstrated that functional
activity and pain are related in OA patients9,21. The moder-
ate correlation between KOOS-PS and HOOS-PS and the
OAKHQOL mental health domain were expected since
this particular subscale has been shown to correlate with
WOMAC pain, and in particular, function domains19. The re-
lationship with OAKHQOL mental health domain was statis-
tically signiﬁcant for HOOS-PS but was not for KOOS-PS.
However, the latter was close to signiﬁcance (P¼ 0.06),
and somewhat close coefﬁcients of correlations were
obtained, which suggest that both are correlated and
that the discrepancy was due to variability in sample
constitution.
A moderate correlation was observed between the
KOOS-PS and the OAKHQOL social functioning domain.
This might be due to the inclusion in this particular OAKH-
QOL domain of two questions (going out whenever one
would like and have friends in whenever one would like)
which might also be related to function. On the contrary,
no relationship was observed between OAKHQOL social
functioning domain and the HOOS-PS. Further studies
are needed to assess whether this discrepancy is due to
variability in sample constitution or is real.
The reliability of the reduced questionnaires was excel-
lent especially considering the time interval between the
two questionnaires. According to the Bland and Altman rep-
resentations, the difference between repeated measure-
ments was not related to the mean of the measurements.
The responsiveness was good or excellent, and might
even be considered as surprisingly high, given the interven-
tion. The evaluation of responsiveness 1 month after hyalur-
onic acid injection might be questionable, particularly for the
hip, since some studies failed to demonstrate any superior-
ity of hyaluronic acid compared to placebo in hip OA22,23.
Thus, the improvement observed in the present study was
probably related to a placebo effect, which has been shown
to be prominent in OA, particularly from injections24.
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Fig. 1. Reproducibility of the French KOOS-PS and HOOS-PS: Bland and Altman representations. Two assessments, separated by a 2-week
interval, were made. 95% Limits of agreement correspond to the mean difference between two measurements 1.96 SD. (a) KOOS-PS and
(b) HOOS-PS.
1607Osteoarthritis and Cartilage Vol. 17, No. 12However, the aim of the study was not to evaluate the
efﬁcacy of hyaluronic acid injection, but to evaluate the re-
sponsiveness of the questionnaires. Moreover, while the
KOOS-PS and HOOS-PS have been shown to capture im-
provement induced by total joint replacement25, it is of sat-
isfaction that the questionnaire demonstrated ability to
capture changes induced by a less valuable intervention.
Finally, it must be pointed out that the 1-month interval
was not too brief, since improvements have been described
as soon as 2 weeks after injection26.
Apart from reliability, validity and responsiveness, a cru-
cial property of an instrument aimed at being used in trials
is feasibility. No ﬂoor or ceiling effects were observed with
the reduced questionnaires. A potential limitation of the
KOOS-PS and HOOS-PS is that, in contrary to the original
KOOS and HOOS in which two missing items per domain
are allowed27, the reduced questionnaires require thatTable II
Construct validity: correlations (Spearman’s r) between KOOS-PS/
HOOS-PS and OAKHQOL subscales
OAKHQOL KOOS-PS HOOS-PS
Physical activities 0.44 (P¼ 0.009) 0.665 (P< 0.001)
Pain 0.366 (P¼ 0.033) 0.385 (P¼ 0.036)
Mental health 0.328 (P¼ 0.06) 0.473 (P< 0.001)
Social support 0.03 (P¼ 0.87) 0.022 (P¼ 0.91)
Social functioning 0.34 (P¼ 0.05) 0.125 (P¼ 0.5)each question is answered. Thus, another satisfying result
was the absence of missing items.
A factorial analysis was not performed since the KOOS-
PS and HOOS-PS were developed to ensure factorial unidi-
mensionality13,14. An additional factor analysis would not
have provided further proof of this. One could object that
the present data were obtained from a new sample. How-
ever, in order to ensure generalizability, the initial develop-
ment of the short measures included large samples across
the spectrum of disease including population-based and
clinically derived samples from multiple countries.
The KOOS-PS and HOOS-PS questionnaires were de-
veloped by a task force working under the umbrella of the
OARSI and OMERACT societies aiming to establish virtual
criteria for total joint replacement to be used as a hard out-
come in therapeutic trials28. To achieve such an objective, it
is critical to use instruments that represent the progressionTable III
Responsiveness of French KOOS-PS and HOOS-PS. Patients
were evaluated prior to and 1 month after three intra-articular
hyaluronic acid injections (KOOS-PS) or 1 month after one intra-
articular hyaluronic acid injection (HOOS-PS)
Pre-hyaluronic acid
injection: mean (SD)
Post-hyaluronic acid
injection: mean (SD)
SRM ES
KOOS-PS 48.2 (15.6) 40.3 (13.9) 0.80 0.51
HOOS-PS 51.3 (16.2) 41.3 (17.4) 1.10 0.62
1608 P. Ornetti et al.: Psychometric properties of KOOS-PS and HOOS-PSof physical disability from early to late disease. The theoret-
ical advantages of KOOS-PS and HOOS-PS are to avoid
redundant items and that the Rasch model creates
interval-scaled measures that provides item difﬁculty
parameters and person functional ability parameters that
are not dependant on each other. An issue might be that
since the reduced questionnaires have been developed
from the KOOS and HOOS, two questionnaires with numer-
ous common items, they might not discriminate knee from
hip OA. Actually, the ﬁve items of HOOS-PS are included
in the KOOS questionnaire, and six out of the seven
KOOS-PS items are included in the HOOS questionnaire.
However, the HOOS-PS and KOOS-PS were not devel-
oped for the discrimination of the two diseases. In addition,
there is only one question common to the HOOS-PS and
KOOS-PS (with actually not exactly the same formulation),
which means that other items of the KOOS-PS did not ﬁt the
Rash model applied to hip OA patients and other items of
the HOOS-PS did not ﬁt the Rash model applied to knee
OA patients. This suggests that the reduced questionnaires
discriminate the two affections.
A previous study of the HOOS-PS and KOOS-PS in peo-
ple with total hip or knee replacement provided evidence of
construct validity and responsiveness of the measures as
compared to the longer WOMAC Likert 3.0 physical function
subscale25 but, to our knowledge, the reliability of the instru-
ments, as well as the construct validity in patients with less
advanced OA and the responsiveness following a less efﬁ-
cient procedure than total joint replacement, have not be as-
sessed. Thus, apart from a validation of the French versions
of the outcomes, the present work, which demonstrates
a satisfying feasibility, convergent and divergent construct
validity, reliability, and responsiveness can be considered
as a further validation study of the new developed knee
and hip OA reduced instruments aimed at assessing func-
tional severity.
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